Singular Genomics Systems Stock Probability of Future Stock Price Finishing Over 0.35
| OMIC Stock | USD 0.35 0.01 2.94% |
Singular |
Singular Genomics Target Price Odds to finish over 0.35
The tendency of Singular Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.35 | 90 days | 0.35 | about 89.94 |
Based on a normal probability distribution, the odds of Singular Genomics to move above the current price in 90 days from now is about 89.94 (This Singular Genomics Systems probability density function shows the probability of Singular Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.02 . This indicates Singular Genomics Systems market returns are highly-sensitive to returns on the market. As the market goes up or down, Singular Genomics is expected to follow. Additionally Singular Genomics Systems has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite. Singular Genomics Price Density |
| Price |
Predictive Modules for Singular Genomics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Singular Genomics Systems. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Singular Genomics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Singular Genomics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Singular Genomics is not an exception. The market had few large corrections towards the Singular Genomics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Singular Genomics Systems, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Singular Genomics within the framework of very fundamental risk indicators.α | Alpha over NYSE Composite | -0.64 | |
β | Beta against NYSE Composite | 1.02 | |
σ | Overall volatility | 0.06 | |
Ir | Information ratio | -0.14 |
Singular Genomics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Singular Genomics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Singular Genomics Systems can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Singular Genomics generated a negative expected return over the last 90 days | |
| Singular Genomics has some characteristics of a very speculative penny stock | |
| Singular Genomics has high historical volatility and very poor performance | |
| Singular Genomics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 2.91 M. Net Loss for the year was (94.82 M) with loss before overhead, payroll, taxes, and interest of (24 K). | |
| Singular Genomics Systems currently holds about 287.98 M in cash with (73.65 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.05, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 14.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Singular Genomics Systems Stock Price Up 4.1 percent - Defense World |
Singular Genomics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Singular Stock often depends not only on the future outlook of the current and potential Singular Genomics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Singular Genomics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 72.8 M | |
| Cash And Short Term Investments | 173.9 M |
Singular Genomics Technical Analysis
Singular Genomics' future price can be derived by breaking down and analyzing its technical indicators over time. Singular Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Singular Genomics Systems. In general, you should focus on analyzing Singular Stock price patterns and their correlations with different microeconomic environments and drivers.
Singular Genomics Predictive Forecast Models
Singular Genomics' time-series forecasting models is one of many Singular Genomics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Singular Genomics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Singular Genomics Systems
Checking the ongoing alerts about Singular Genomics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Singular Genomics Systems help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Singular Genomics generated a negative expected return over the last 90 days | |
| Singular Genomics has some characteristics of a very speculative penny stock | |
| Singular Genomics has high historical volatility and very poor performance | |
| Singular Genomics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 2.91 M. Net Loss for the year was (94.82 M) with loss before overhead, payroll, taxes, and interest of (24 K). | |
| Singular Genomics Systems currently holds about 287.98 M in cash with (73.65 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.05, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 14.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Singular Genomics Systems Stock Price Up 4.1 percent - Defense World |
Additional Information and Resources on Investing in Singular Stock
When determining whether Singular Genomics Systems offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Singular Genomics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Singular Genomics Systems Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Singular Genomics Systems Stock:Check out Singular Genomics Backtesting, Singular Genomics Valuation, Singular Genomics Correlation, Singular Genomics Hype Analysis, Singular Genomics Volatility, Singular Genomics History as well as Singular Genomics Performance. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Singular Genomics. If investors know Singular will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Singular Genomics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.31) | Revenue Per Share 0.034 | Quarterly Revenue Growth (0.49) | Return On Assets (0.23) | Return On Equity (0.48) |
The market value of Singular Genomics Systems is measured differently than its book value, which is the value of Singular that is recorded on the company's balance sheet. Investors also form their own opinion of Singular Genomics' value that differs from its market value or its book value, called intrinsic value, which is Singular Genomics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Singular Genomics' market value can be influenced by many factors that don't directly affect Singular Genomics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Singular Genomics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Singular Genomics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Singular Genomics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.